Omicron subvariants illustrate reduced respiratory tissue penetration, cell damage and inflammatory responses in human airway epithelia
IntroductionTo explore whether the reported lower pathogenicity in infected individuals of variant of concern (VoC) Omicron and its current subvariants compared to VoC Delta may be related to fundamental differences in the initial virus-tissue interaction, we assessed their ability to penetrate, rep...
Main Authors: | Viktoria Zaderer, Hussam Abd El Halim, Anna-Lena Wyremblewsky, Gaia Lupoli, Christopher Dächert, Maximilian Muenchhoff, Alexander Graf, Helmut Blum, Cornelia Lass-Flörl, Oliver T. Keppler, Lukas A. Huber, Wilfried Posch, Doris Wilflingseder |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1258268/full |
Similar Items
-
Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern
by: Gabriel Diem, et al.
Published: (2023-10-01) -
Global Distribution, Dispersal Patterns, and Trend of Several Omicron Subvariants of SARS-CoV-2 across the Globe
by: Ioannis Kopsidas, et al.
Published: (2022-11-01) -
ColdZyme® protects airway epithelia from infection with BA.4/5
by: Zaderer Viktoria, et al.
Published: (2022-10-01) -
Correction: ColdZyme® protects airway epithelia from infection with BA.4/5
by: Viktoria Zaderer, et al.
Published: (2023-01-01) -
Immune Evasion of SARS-CoV-2 Omicron Subvariants
by: Hanzhong Ke, et al.
Published: (2022-09-01)